Although the BAX gene polymorphism in our study on whether increasing cancer susceptibility was not statistically significant, and the results are consistent even with subgroup analyses based on race and control group sources, we still cannot ignore the interaction between it and other genes on cancer susceptibility, such as TP53, BCL2, and so on. The gene discussed is BCL2; the disease is cancer.